UK gov­ern­ment backs $189M ef­fort to bol­ster life sci; Bay­er files he­mo­phil­ia drug; Akcea files volane­sors­en NDA

⇨ With Brex­it loom­ing, the UK gov­ern­ment is par­tic­u­lar­ly anx­ious about pre­serv­ing and grow­ing its big bio­phar­ma sec­tor. With that in mind the gov­ern­ment has come up with a near-term plan to in­vest $189 mil­lion in the sec­tor, look­ing to spur new in­no­va­tion in drug and vac­cine de­vel­op­ment as well as phar­ma­ceu­ti­cal man­u­fac­tur­ing. Bloomberg re­ports that Prime Min­is­ter There­sa May has se­lect­ed the life sci­ences in­dus­try, which em­ploys more than 235,000, as one of five vi­tal to eco­nom­ic health.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER